media
In The News
Braeden Lichti and INmune Bio at the Nasdaq Bell Ringing Carmony
Braeden Lichti and Northstrive Team Celebrates PMGC Holdings Listing On Nasdaq
Featured By Greater Sacramento Economic Council
“Elevai Labs’ growth is a testament to the thriving biotech ecosystem in Greater Sacramento.”
In 2020, Braeden Lichti became the first and largest investor in Northern California-based Elevai Labs. NorthStrive was later contracted to lead the company to IPO and eventual sale in 2024 — recognized by the Greater Sacramento Economic Council as a biotech success story.
Latest News
media
More News
NorthStrive Companies Inc. Announces Advisory Role to NorthStrive Acquisition Corp I. Following Public Filing for Proposed $100 Million Initial Public Offering
NorthStrive® Companies Inc. Co-Advises on Acquisition of A&B Aerospace, Inc.
The Capital Allocation Reckoning: Braeden Lichti Outlines the Time Failed Biotechs Should Wind Down and Return Shareholder Cash
NorthStrive® Companies Inc. Co-Advises on Acquisition of SVM Machining, Inc.
NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries
NorthStrive® Companies Inc. Advises on the Successful Closing of the Acquisition of Indarg Engineering, Inc., a California-Based Precision CNC Manufacturer
NorthStrive® Companies Inc. Advises and Leads the Successful Closing of Two Strategic California Manufacturing Acquisitions
The G.A.G.E.™ Framework: NorthStrive Companies Operating Model for Long-Term Value Creation by CEO Braeden Lichti and Co.
Braeden Lichti Lived Through the 2008 Market Crash—Now He’s Advising Investors to Tune Out the Noise and Focus on What Matters
Northstrive Biosciences Invited to Present at UCLA Symposium on Anti-Obesity Treatments Addressing Muscle Preservation
Events
2025 Our Holiday Event
See Gallery
Our Services
Companies
Career Oportunities
GAGE
Events & Media
Giving Back
Downloads
Contact